Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg

Mostrar otras versiones (1)

Background. We compared the prevalence of SARS-CoV-2 IgG/IgM in multiple sclerosis (MS), low-risk, and high-risk populations and explored possible clinical correlates. Methods. In this cross-sectional study, we recruited MS patients, low-risk (university staff from non-clinical departments), and hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Capasso, Nicola, Palladino, Raffaele, Montella, Emma, Pennino, Francesca, Lanzillo, Roberta, Carotenuto, Antonio, Petracca, Maria, Iodice, Rosa, Iovino, Aniello, Aruta, Francesco, Pastore, Viviana, Buonomo, Antonio Riccardo, Zappulo, Emanuela, Gentile, Ivan, Triassi, Maria, Brescia Morra, Vincenzo, Moccia, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766741/
https://www.ncbi.nlm.nih.gov/pubmed/33339402
http://dx.doi.org/10.3390/jcm9124066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766741/
https://www.ncbi.nlm.nih.gov/pubmed/33339402
http://dx.doi.org/10.3390/jcm9124066

Ejemplares similares